
Fulgent Genetics FLGT
$ 26.89
-0.92%
Quarterly report 2025-Q3
added 11-07-2025
Fulgent Genetics DPO Ratio 2011-2025 | FLGT
Annual DPO Ratio Fulgent Genetics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 34.9 | 38 | 31.6 | 39.8 | 57 | 40.9 | 44.8 | 89.2 | 150 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 150 | 31.6 | 58.4 |
Quarterly DPO Ratio Fulgent Genetics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 34.7 | 35.8 | 37 | - | 40.2 | 40.5 | 37.6 | - | 37 | 41.2 | 43.5 | - | 11.1 | 18 | 25.9 | 33.3 | 41.6 | 41 | 27.1 | 46.7 | 92 | 313 | 316 | 39.7 | 37.1 | 39.9 | 44.5 | 43.3 | 45.9 | 47.1 | 56 | 74.9 | 84 | 101 | 119 | 135 | 117 | 178 | 107 | 10.5 | 15.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 316 | 10.5 | 68.7 |
DPO Ratio of other stocks in the Diagnostics research industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M | ||
|
DarioHealth Corp.
DRIO
|
43.9 | $ 12.08 | 1.6 % | $ 343 M | ||
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M | ||
|
DexCom
DXCM
|
70.4 | $ 66.05 | -1.36 % | $ 25.5 B | ||
|
Burning Rock Biotech Limited
BNR
|
125 | $ 16.21 | 2.92 % | $ 174 M | ||
|
Exact Sciences Corporation
EXAS
|
139 | $ 101.54 | 0.04 % | $ 18.8 B | ||
|
Accelerate Diagnostics
AXDX
|
125 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
104 | $ 1.57 | -2.88 % | $ 2 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M | ||
|
Castle Biosciences
CSTL
|
52 | $ 38.67 | 0.09 % | $ 1.07 B | ||
|
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | ||
|
Danaher Corporation
DHR
|
66.4 | $ 226.56 | 0.1 % | $ 166 B | ||
|
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | ||
|
Mettler-Toledo International
MTD
|
53.4 | $ 1 410.21 | 1.19 % | $ 29.9 B | ||
|
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | ||
|
NeoGenomics
NEO
|
20.7 | $ 12.03 | 1.52 % | $ 1.52 B | ||
|
Neogen Corporation
NEOG
|
62.7 | $ 6.79 | -1.02 % | $ 1.47 B | ||
|
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
44.2 | $ 19.88 | -3.31 % | $ 1.07 B | ||
|
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K | ||
|
Pacific Biosciences of California
PACB
|
33.5 | $ 2.12 | - | $ 538 M | ||
|
Anixa Biosciences
ANIX
|
1.29 K | $ 3.32 | -7.26 % | $ 106 K | ||
|
Co-Diagnostics
CODX
|
106 | $ 0.31 | -9.29 % | $ 9.1 M | ||
|
IQVIA Holdings
IQV
|
126 | $ 222.81 | 0.27 % | $ 40.4 B | ||
|
Precipio
PRPO
|
53 | $ 24.67 | -1.2 % | $ 32 M | ||
|
Quidel Corporation
QDEL
|
101 | $ 28.84 | 0.14 % | $ 1.21 B | ||
|
QIAGEN N.V.
QGEN
|
50 | $ 45.08 | -0.31 % | $ 10 B | ||
|
Guardant Health
GH
|
83.6 | $ 103.85 | 1.74 % | $ 12.7 B | ||
|
Aspira Women's Health
AWH
|
112 | - | -6.19 % | $ 10.5 M | ||
|
Sotera Health Company
SHC
|
46.2 | $ 16.84 | 0.03 % | $ 4.76 B | ||
|
Soleno Therapeutics
SLNO
|
130 | $ 49.87 | -4.1 % | $ 2 B | ||
|
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
56.3 | $ 134.53 | -0.25 % | $ 21.4 B | ||
|
Charles River Laboratories International
CRL
|
24.5 | $ 197.25 | 2.19 % | $ 10.1 B | ||
|
Thermo Fisher Scientific
TMO
|
49.3 | $ 572.13 | 0.08 % | $ 219 B | ||
|
Trinity Biotech plc
TRIB
|
163 | $ 0.96 | -10.3 % | $ 61.9 M | ||
|
Quotient Limited
QTNT
|
86.2 | - | -11.32 % | $ 1.1 M | ||
|
Twist Bioscience Corporation
TWST
|
12.5 | $ 31.04 | 0.36 % | $ 1.86 B | ||
|
Quest Diagnostics Incorporated
DGX
|
18.3 | $ 184.03 | 0.81 % | $ 20.4 B | ||
|
Myriad Genetics
MYGN
|
42 | $ 6.98 | -3.26 % | $ 632 M |